• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自然杀伤细胞活性作为高危患者肺癌诊断的生物标志物。

Natural killer cell activity as a biomarker for the diagnosis of lung cancer in high-risk patients.

机构信息

Department of Respiratory Diseases, Aalborg University Hospital, Aalborg, Denmark.

Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.

出版信息

J Int Med Res. 2022 Jun;50(6):3000605221108924. doi: 10.1177/03000605221108924.

DOI:10.1177/03000605221108924
PMID:35770523
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9251988/
Abstract

OBJECTIVE

Natural killer (NK) cells play an essential role in the immune response against cancer. However, immune escape mechanisms may cause inferior NK cell activity (NKA) in patients with cancer. This prospective study examined the relationship between NKA and lung cancer in a high-risk cohort.

METHODS

In a cohort study, 250 participants referred by their general practitioner for suspicion of lung cancer were included. Before clinical investigation, blood was collected into NK Vue tubes, and the level of interferon gamma after 24 hours served as a surrogate marker for NKA.

RESULTS

Among 250 patients, 79 were diagnosed with lung cancer. No difference in NKA was found between patients with lung cancer and control participants in which lung cancer was ruled out (median 226 pg/mL vs. 450 pg/mL). However, there was a significant difference in NKA between patients with late-stage lung cancer and controls (median 161 pg/mL vs. 450 pg/mL). A linear regression model showed that NKA was not influenced by age, sex or smoking status.

CONCLUSIONS

The significantly lower NKA in patients with late-stage lung cancer warrants further investigation combining NKA with other biomarkers and examining the potential role of NKA as a marker of disseminated disease.

摘要

目的

自然杀伤 (NK) 细胞在抗肿瘤免疫反应中发挥着重要作用。然而,免疫逃逸机制可能导致癌症患者的 NK 细胞活性 (NKA) 降低。本前瞻性研究在高危人群中研究了 NKA 与肺癌之间的关系。

方法

在一项队列研究中,纳入了 250 名由全科医生转介怀疑患有肺癌的患者。在临床检查之前,将血液采集到 NK Vue 管中,24 小时后干扰素γ的水平可作为 NKA 的替代标志物。

结果

在 250 名患者中,有 79 名被诊断患有肺癌。患有肺癌的患者与排除肺癌的对照组之间的 NKA 无差异(中位数分别为 226pg/mL 和 450pg/mL)。然而,晚期肺癌患者与对照组之间的 NKA 存在显著差异(中位数分别为 161pg/mL 和 450pg/mL)。线性回归模型显示,NKA 不受年龄、性别或吸烟状况的影响。

结论

晚期肺癌患者的 NKA 明显降低,需要进一步结合 NKA 与其他生物标志物进行研究,并研究 NKA 作为播散性疾病标志物的潜在作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb68/9251988/0bdbce1c4cb4/10.1177_03000605221108924-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb68/9251988/3a8b80fb0dcc/10.1177_03000605221108924-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb68/9251988/8d43b058333e/10.1177_03000605221108924-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb68/9251988/0bdbce1c4cb4/10.1177_03000605221108924-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb68/9251988/3a8b80fb0dcc/10.1177_03000605221108924-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb68/9251988/8d43b058333e/10.1177_03000605221108924-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb68/9251988/0bdbce1c4cb4/10.1177_03000605221108924-fig3.jpg

相似文献

1
Natural killer cell activity as a biomarker for the diagnosis of lung cancer in high-risk patients.自然杀伤细胞活性作为高危患者肺癌诊断的生物标志物。
J Int Med Res. 2022 Jun;50(6):3000605221108924. doi: 10.1177/03000605221108924.
2
Lower postoperative natural killer cell activity is associated with positive surgical margins after radical prostatectomy.根治性前列腺切除术后,术后自然杀伤细胞活性降低与切缘阳性相关。
J Formos Med Assoc. 2020 Nov;119(11):1673-1683. doi: 10.1016/j.jfma.2019.12.015. Epub 2020 Feb 17.
3
Clinical utility of a novel natural killer cell activity assay for diagnosing non-small cell lung cancer: a prospective pilot study.一种新型自然杀伤细胞活性检测方法在诊断非小细胞肺癌中的临床应用:一项前瞻性初步研究。
Onco Targets Ther. 2019 Feb 27;12:1661-1669. doi: 10.2147/OTT.S194473. eCollection 2019.
4
A high-throughput assay of NK cell activity in whole blood and its clinical application.一种高通量检测全血 NK 细胞活性的方法及其临床应用。
Biochem Biophys Res Commun. 2014 Mar 14;445(3):584-90. doi: 10.1016/j.bbrc.2014.02.040. Epub 2014 Feb 18.
5
Correlation Between Natural Killer Cell Activity and Systemic Inflammatory Markers for Heterogeneous Cancer Patients Treated With Wheel Balance Cancer Therapy.接受轮平衡癌症疗法治疗的异质性癌症患者自然杀伤细胞活性与全身炎症标志物之间的相关性
Integr Cancer Ther. 2018 Jun;17(2):322-331. doi: 10.1177/1534735417717789. Epub 2017 Jul 17.
6
Reduction of the CD16(-)CD56bright NK cell subset precedes NK cell dysfunction in prostate cancer.CD16(-)CD56brightNK 细胞亚群减少先于前列腺癌 NK 细胞功能障碍。
PLoS One. 2013 Nov 4;8(11):e78049. doi: 10.1371/journal.pone.0078049. eCollection 2013.
7
Vitamin D and Exercise Are Major Determinants of Natural Killer Cell Activity, Which Is Age- and Gender-Specific.维生素 D 和运动是自然杀伤细胞活性的主要决定因素,而自然杀伤细胞活性具有年龄和性别特异性。
Front Immunol. 2021 Jun 23;12:594356. doi: 10.3389/fimmu.2021.594356. eCollection 2021.
8
A Comparison of Cellular Immune Response and Immunological Biomarkers in Laparoscopic Surgery for Colorectal Cancer and Benign Disorders.腹腔镜结直肠癌与良性疾病手术的细胞免疫反应和免疫生物标志物比较。
Clin Colorectal Cancer. 2024 Dec;23(4):372-381.e1. doi: 10.1016/j.clcc.2024.05.012. Epub 2024 Jun 18.
9
Higher natural killer cell activity in schizophrenic patients: the impact of serum factors, medication, and smoking.
Brain Behav Immun. 2000 Sep;14(3):153-69. doi: 10.1006/brbi.1999.0574.
10
Association between natural killer cell activity and prostate cancer: a pilot study.自然杀伤细胞活性与前列腺癌之间的关联:一项初步研究。
Can J Urol. 2017 Apr;24(2):8708-8713.

引用本文的文献

1
Natural killer cell activity in metastatic castration resistant prostate cancer patients treated with enzalutamide.转移性去势抵抗性前列腺癌患者接受恩扎卢胺治疗后的自然杀伤细胞活性。
Sci Rep. 2023 Oct 10;13(1):17144. doi: 10.1038/s41598-023-43937-7.
2
Gross Total Resection Promotes Subsequent Recovery and Further Enhancement of Impaired Natural Killer Cell Activity in Glioblastoma Patients.全切除可促进胶质母细胞瘤患者的后续恢复并进一步增强受损自然杀伤细胞活性
Brain Sci. 2022 Aug 27;12(9):1144. doi: 10.3390/brainsci12091144.

本文引用的文献

1
Performance of the EarlyCDT® Lung test in detection of lung cancer and pulmonary metastases in a high-risk cohort.早期 CDT® 肺试验在高危人群中检测肺癌和肺转移的性能。
Lung Cancer. 2021 Aug;158:85-90. doi: 10.1016/j.lungcan.2021.06.010. Epub 2021 Jun 10.
2
NK Cells in Autoimmune Diseases: Protective or Pathogenic?自然杀伤细胞在自身免疫性疾病中的作用:保护还是致病?
Front Immunol. 2021 Mar 12;12:624687. doi: 10.3389/fimmu.2021.624687. eCollection 2021.
3
Efficacy of natural killer cell activity as a biomarker for predicting immunotherapy response in non-small cell lung cancer.
自然杀伤细胞活性作为预测非小细胞肺癌免疫治疗反应的生物标志物的疗效。
Thorac Cancer. 2020 Nov;11(11):3337-3345. doi: 10.1111/1759-7714.13677. Epub 2020 Oct 5.
4
Impact of Smoking on Human Natural Killer Cell Activity: A Large Cohort Study.吸烟对人类自然杀伤细胞活性的影响:一项大型队列研究。
J Cancer Prev. 2020 Mar 30;25(1):13-20. doi: 10.15430/JCP.2020.25.1.13.
5
Unleashing Natural Killer Cells in the Tumor Microenvironment-The Next Generation of Immunotherapy?在肿瘤微环境中释放自然杀伤细胞——下一代免疫疗法?
Front Immunol. 2020 Feb 21;11:275. doi: 10.3389/fimmu.2020.00275. eCollection 2020.
6
Current Cancer Epidemiology.当代癌症流行病学。
J Epidemiol Glob Health. 2019 Dec;9(4):217-222. doi: 10.2991/jegh.k.191008.001.
7
Natural killer cell activity and prostate cancer risk in veteran men undergoing prostate biopsy.自然杀伤细胞活性与接受前列腺活检的老年男性前列腺癌风险。
Cancer Epidemiol. 2019 Oct;62:101578. doi: 10.1016/j.canep.2019.101578. Epub 2019 Aug 1.
8
Next-generation sequencing in liquid biopsy: cancer screening and early detection.液体活检中的下一代测序:癌症筛查和早期检测。
Hum Genomics. 2019 Aug 1;13(1):34. doi: 10.1186/s40246-019-0220-8.
9
Correlation Between Natural Killer Cell Activity and Treatment Effect in Patients with Disseminated Cancer.播散性癌症患者自然杀伤细胞活性与治疗效果的相关性
Transl Oncol. 2019 Jul;12(7):968-972. doi: 10.1016/j.tranon.2019.04.002. Epub 2019 May 16.
10
Clinical utility of a novel natural killer cell activity assay for diagnosing non-small cell lung cancer: a prospective pilot study.一种新型自然杀伤细胞活性检测方法在诊断非小细胞肺癌中的临床应用:一项前瞻性初步研究。
Onco Targets Ther. 2019 Feb 27;12:1661-1669. doi: 10.2147/OTT.S194473. eCollection 2019.